ABSTRACT
Two major proteoglycans, which appear to be structurally closely related, were isolated from bovine chromaffin granule matrix proteins by ion-exchange chromatography. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis they have apparent average molecular sizes of 35-40 kDa (range of 23-75 kDa) and generate a 14-kDa core glycoprotein after chondroitinase treatment. Previous studies demonstrated that these two major chromaffin granule proteoglycans are very similar in terms of their peptide mapping patterns and carbohydrate composition (having a high proportion of tri- and tetraantennary N-glycosidic oligosaccharides, and O-glycosidic oligosaccharides consisting predominantly of disialyl derivatives of galactosyl(beta 1-3)N-acetylgalactosamine), and that they differed in these respects from the chromogranins. By using antisera to five synthetic peptide fragments of chromogranin A to stain immunoblots of purified chromaffin granule proteoglycans before and after chondroitinase treatment, we have now shown that these major proteoglycans are not immunochemically related to chromogranin A. However, it has recently been reported that some chromogranin A-immunoreactive material disappears after chondroitinase treatment, and our studies demonstrate that approximately 1-2% of the chromogranin A occurs in the form of a 110-kDa proteoglycan, which is converted to a 95-kDa core glycoprotein after chondroitinase treatment. Similar chromogranin A proteoglycans could be detected in rat PC12 pheochromocytoma cells, where they have a molecular size of 115-145 kDa and yield a 105-kDa core protein after chondroitinase treatment. Studies using antibodies to synthetic peptide fragments of chromogranin B (secretogranin I) did not provide any evidence that this related protein occurs in a proteoglycan form.
Subject(s)
Adrenal Gland Neoplasms/analysis , Chondroitin Sulfate Proteoglycans/isolation & purification , Chromaffin Granules/analysis , Chromaffin System/analysis , Chromogranins/analysis , Nerve Tissue Proteins/analysis , Pheochromocytoma/analysis , Proteoglycans/isolation & purification , Animals , Cattle , Chondroitin Sulfate Proteoglycans/immunology , Chromogranin A , Cross Reactions , Electrophoresis, Polyacrylamide Gel , Immunoblotting , Rats , Tumor Cells, Cultured/analysisABSTRACT
Antibodies to the Alzheimer disease (AD) beta-amyloid peptide (beta AP) were used to identify beta AP precursor fragments in blood. The antibodies detected 3 major polypeptides with apparent molecular weights (MW) of 47-64,000 in Western blots of plasma derived clot proteins, but these proteins corresponded to human A-alpha, B-beta and gamma-fibrinogen since they reacted with 2 different anti-fibrinogen antisera, and the anti-beta AP and anti-fibrinogen antibodies recognized purified fibrinogen and fibrin. These data are significant for efforts to develop immunochemical assays to diagnose and monitor the progression of AD.
Subject(s)
Amyloid/immunology , Epitopes/analysis , Fibrinogen/immunology , Nerve Tissue Proteins/immunology , Adrenal Gland Neoplasms/analysis , Alzheimer Disease/metabolism , Amyloid/analysis , Amyloid beta-Peptides , Animals , Antibodies , Antibodies, Monoclonal , Blotting, Western , Brain Chemistry , Cross Reactions , Enzyme-Linked Immunosorbent Assay , Humans , Pheochromocytoma/analysis , Protein Conformation , RatsABSTRACT
CRH, GH-releasing hormone (GHRH), somatostatin (SRIH), and peptide histidine methionine (PHM) were measured by RIA in extracts of normal adrenal glands and in extracts from adrenal and extraadrenal pheochromocytomas. In normal adrenal glands, immunoreactive (IR) CRH, IR-SRIH, and IR-PHM were detectable, while IR-GHRH was undetectable. In all 11 cases of adrenal pheochromocytomas, the tumors contained 2 or more of these four IR-peptides. In particular, IR-CRH was found in 73% (n = 8) of adrenal pheochromocytomas, IR-GHRH in 91% (n = 10), IR-SRIH in 91% (n = 10), and IR-PHM in 82% (n = 9) of adrenal pheochromocytomas. There was no significant correlation among the concentration of these peptides in each tumor, i.e. the concentrations of the IR-peptides were independent of each other. In contrast to the adrenal pheochromocytomas, none of these 4 IR-peptides was detectable in 5 extraadrenal pheochromocytomas. Gel filtration of pooled extracts from adrenal pheochromocytomas showed that the major component of the IR-CRH, IR-GHRH, IR-SRIH, and IR-PHM eluted in the position of their synthetic counterparts. Our results suggest that 1) the normal adrenal gland contains IR-CRH, IR-SRIH, and IR-PHM, but not IR-GHRH; 2) all of the adrenal pheochromocytomas we examined contained a number of hypothalamic releasing or inhibiting hormones; 3) their tissue concentrations were independent of each other; and 4) all of the extraadrenal pheochromocytomas we examined contained no such IR-peptides. The presence of hypothalamic hormones in adrenal pheochromocytomas and their absence in extraadrenal pheochromocytomas may be due to the differences in the chromaffin cells of their origin. Our data may be helpful in the differential diagnosis between adrenal and extraadrenal pheochromocytomas.
Subject(s)
Adrenal Gland Neoplasms/analysis , Corticotropin-Releasing Hormone/analysis , Growth Hormone-Releasing Hormone/analysis , Peptide PHI/analysis , Pheochromocytoma/analysis , Somatostatin/analysis , Adrenal Glands/analysis , Adult , Aged , Chromatography, Gel , Female , Humans , Male , Middle Aged , Radioimmunoassay , Tissue Extracts/analysisABSTRACT
Synenkephalin (SYN), the nonopioid amino-terminal portion of proenkephalin (PRO), is stable and well conserved in mammals and therefore a promising marker for PRO systems. We immunized rabbits with synthetic [Tyr63]SYN(63-70)-octapeptide, coupled by glutaraldehyde to bovine serum albumin. In radioimmunoassay (RIA) using antiserum no. 681, [Tyr63]SYN(63-70)-octapeptide as standard, and 125I-[Tyr63]SYN(63-70)-octapeptide as tracer, the IC50 was approximately 51 fmol/100-microliters sample at equilibrium or 12 fmol/100 microliters in disequilibrium, and the sensitivity was approximately 3 fmol/100 microliters. Cross-reactivity of the assay was 100% with [Cys63]SYN(63-70)-octapeptide and with bovine adrenal 8.6-kilodalton peptide digested with trypsin and carboxypeptidase B, but less than 0.1% with transforming growth factor-alpha, less than or equal to 2 x 10(-6) with Leu-Leu-Ala [SYN(68-70)-tripeptide], and much less than 10(-6) with all other peptides tested. Therefore in RIA this antiserum is specific for the free carboxyl terminus of SYN. Because the peptide detected after enzyme digestion is the complete SYN(63-70)-octapeptide, we refer to the RIA as an assay for SYN(63-70). Tissue extracts were made in 1 M acetic acid, dried, reconstituted in Tris-CaCl2, and digested sequentially with trypsin plus carboxypeptidase B. Extracts from bovine corpus striatum gave SYN(63-70) RIA dilution curves parallel to the standard curve both before and after digestion. Digestion increased the amount of immunoreactive SYN(63-70) in striatum by a factor of 1.5-2.0. The ratio of total immunoreactive [Met5]enkephalin to total immunoreactive SYN(63-70) (after sequential digestion) was approximately 6:1. At least 90% of the immunoreactive SYN(63-70) in extracts of bovine caudate nucleus eluted from Sephadex G-100 with an apparent molecular weight equal to that of bovine PRO(1-77). Using the new RIA we were able to detect and characterize SYN processing for the first time in extracts of whole rat brain, human globus pallidus, and human pheochromocytoma. Results in these tissues were similar to those in cattle, in that most stored SYN had been processed to a free carboxyl terminus. Since the C-terminal octapeptide of SYN is practically identical in all known mammalian PRO, antiserum no. 681 should be useful for detecting, measuring, and purifying SYN from various mammals, including human beings.
Subject(s)
Enkephalins/analysis , Immune Sera/immunology , Protein Precursors/analysis , Adrenal Gland Neoplasms/analysis , Animals , Brain Chemistry , Cattle , Caudate Nucleus/analysis , Chemical Phenomena , Chemistry , Chromatography, Gel , Enkephalins/immunology , Globus Pallidus , Humans , Pheochromocytoma/analysis , Protein Precursors/immunology , Radioimmunoassay/standards , RatsABSTRACT
Seven monoclonal antibodies (MAbs) directed to tetrasialoganglioside (GQ1b) were established, purified GQ1b being used for immunization and hybridoma screening. All of the MAbs reacted strongly with GQ1b, although they also reacted with other gangliosides, with different specificities and reactivities. Some MAbs (1H10, 2C7, and 3F4) reacted with GD3, GT1a, GQ1b, and GP1c. MAb 1H4 showed broad specificity. It reacted with GD3, GD1b, GD2, GT1a, GT1b, GO1b, GQ1c, and GP1c. MAbs 7F5, 4E7, and 4F10 recognized GT1a, GQ1b, and GP1c. MAb 4F10 was more specific for GQ1b than the other MAbs. Using MAb 4F10, we determined, by means of an immunoassay, the quantities of endogenous GQ1b in some neuronal and adrenal cell lines, GOTO (human neuroblastoma), Neuro2a (mouse neuroblastoma), and PC12 (rat pheochromocytoma). PC12 and Neuro2a cells contained at least 5.1 X 10(6) and 3.9 X 10(5) molecules/cell of GQ1b, respectively. In contrast, no GQ1b was detected in GOTO cells, which are known for their specific neuritogenic response to this particular ganglioside when exogenously added.
Subject(s)
Adrenal Gland Neoplasms/analysis , Antibodies, Monoclonal , Gangliosides/analysis , Neuroblastoma/analysis , Pheochromocytoma/analysis , Animals , Antibodies, Monoclonal/immunology , Gangliosides/immunology , Humans , Tumor Cells, CulturedABSTRACT
Chromogranins A, B, and C, proteins that are co-stored and co-released with peptides and amines, have been identified in a variety of neuroendocrine tissues, both normal and neoplastic. We examined the secretion of chromogranin A and chromogranin A + B by hormone-producing tumours in patients with endocrine pancreatic tumours, carcinoid tumours, pheochromocytomas, and small cell lung cancer. The radioimmunoassay determining the plasma concentrations of chromogranin A + B showed a greater sensitivity than that determining chromogranin A alone. All patients with endocrine pancreatic tumours, carcinoids, and pheochromocytomas had increased levels of chromogranin A + B, whereas a small number of the patients (5/18 with endocrine pancreatic tumours and 1/3 with pheochromocytomas) had normal levels of chromogranin A. Also in immunocytochemical stainings, our polyclonal antiserum detecting both chromogranin A and B showed a greater sensitivity than other available antisera against chromogranin A, B and C. We have demonstrated that a polyclonal antiserum against a mixture of chromogranin A and B might be a more sensitive marker than chromogranin A alone for diagnosing neuroendocrine tumours. This is not surprising, since both chromogranins are widely distributed in neuroendocrine cells.
Subject(s)
Biomarkers, Tumor/blood , Carcinoid Tumor/blood , Chromogranins/immunology , Immune Sera/analysis , Nerve Tissue Proteins/immunology , Pancreatic Neoplasms/blood , Pheochromocytoma/blood , Amino Acids/analysis , Animals , Carcinoid Tumor/ultrastructure , Chromogranin A , Chromogranins/analysis , Humans , Immune Sera/biosynthesis , Immunohistochemistry , Pancreatic Neoplasms/ultrastructure , Pheochromocytoma/analysis , Pheochromocytoma/ultrastructure , Radioimmunoassay , RatsABSTRACT
We examined c-fos and c-myc expressions in pheochromocytoma tissues from six patients. All samples contained c-fos and c-myc transcripts, whereas mRNA from bovine adrenal medulla, as a control, did not contain these transcripts at detectable levels. Southern blot analysis revealed no amplification and no rearrangement of c-fos and c-myc genes. We also examined the gene expression of insulin-like growth factor-II (IGF-II), a mitogen for rat pheochromocytoma cells exerted by autocrine or paracrine fashion. All samples from the pheochromocytomas contained IGF-II transcripts as well as c-fos and c-myc transcripts. The constitutive expressions of c-fos and c-myc genes may be interpreted to mean that pheochromocytoma is in a state of growth stimulation in vivo by growth factors, including IGF-II.
Subject(s)
Adrenal Gland Neoplasms/genetics , Gene Expression Regulation, Neoplastic , Pheochromocytoma/genetics , Proto-Oncogenes , Adrenal Gland Neoplasms/analysis , Adult , Blotting, Northern , Blotting, Southern , DNA, Neoplasm/analysis , Female , Humans , Male , Middle Aged , Molecular Probe Techniques , Nucleic Acid Hybridization , Pheochromocytoma/analysis , RNA, Messenger/analysis , RNA, Neoplasm/analysisABSTRACT
Immunohistochemical studies for methionine- and leucine-enkephalin were performed on 26 phaeochromocytomas to elucidate the patho-physiological roles of enkephalins. Positive reactions were seen in all phaeochromocytomas with varying intensities. The location of methionine- and leucine-enkephalin agreed fairly well with each other. Stronger immunostaining was obtained in phaeochromocytomas secreting both adrenalin and noradrenaline than in those secreting predominantly noradrenaline. Paroxysmal hypertension was frequently observed in patients with adrenalin-secreting phaeochromocytomas, especially those with marked enkephalin positivity. Urinary excretion of metanephrine was significantly correlated with enkephalin positivity. These findings show that all phaeochromocytomas retain the ability to produce enkephalins of the adreno-medullary or extra-medullary chromaffin tissues from which they derive. Augmented enkephalin-immunoreactivity in adrenalin-producing phaeochromocytomas may be interpreted as reflecting a close association of enkephalins with adrenalin under physiological conditions.
Subject(s)
Adrenal Gland Neoplasms/analysis , Enkephalins/analysis , Pheochromocytoma/analysis , Adrenal Gland Neoplasms/pathology , Adult , Aged , Epinephrine/metabolism , Female , Humans , Immunohistochemistry , Male , Middle Aged , Pheochromocytoma/metabolism , Pheochromocytoma/pathologyABSTRACT
Neuroendocrine features of 30 surgically removed adrenal pheochromocytomas were evaluated combining conventional histochemistry and immunocytology. The reactivity for neuron-specific enolase (NSE), S-100 protein, vasoactive intestinal peptide (VIP), calcitonin and ACTH was tested according to the peroxidase anti-peroxidase (PAP) method using polyclonal antibodies. The neuroendocrine marker NSE was found in all cases. S-100 protein was present in satellite cells in 11 (36.6%) tumors. Rare immunoreactive cells for somatostatin were found in 16 (53.3%), for VIP in 8 (26.6%), for calcitonin in 7 (23%), and for ACTH in 3 (10%) cases. Our results proved the histological and functional heterogeneity of pheochromocytomas. The multiple synthetic activity is their inherent feature as in other neuroendocrine tumors.
Subject(s)
Adrenal Gland Neoplasms/pathology , Neuropeptides/analysis , Pheochromocytoma/pathology , Adolescent , Adrenal Gland Neoplasms/analysis , Adrenocorticotropic Hormone/analysis , Adult , Calcitonin/analysis , Humans , Immunohistochemistry , Middle Aged , Pheochromocytoma/analysis , Somatostatin/analysisABSTRACT
We have previously described the isolation of a cDNA clone corresponding to an mRNA rapidly induced to high levels in PC12 cells by treatment with NGF. We report here the complete amino acid sequence of the protein (named VGF8a) as deduced by nucleotide sequencing of overlapping cDNA clones. VGF8a is particularly rich in proline residues and has a conspicuous number of short stretches of basic amino acid residues which may represent potential targets for proteolytic cleavage. Antibodies directed against recombinant VGF8a-beta-galactosidase fusion proteins were used for immunofluorescent staining of the protein in PC12 cells as well as for its localization, by Western blot analysis, in subfractions of cell homogenates. We demonstrate that in PC12 cells, VGF8a protein is stored in secretory vesicles and is released in response to a variety of stimuli that are known to induce the regulated secretion of neurotransmitters.
Subject(s)
Cytoplasmic Granules/analysis , Nerve Growth Factors/pharmacology , Nerve Tissue Proteins/analysis , Adrenal Gland Neoplasms/analysis , Amino Acid Sequence , Animals , Antibodies , Blotting, Western , Cytoplasmic Granules/metabolism , DNA/genetics , Fluorescent Antibody Technique , Gene Expression Regulation , Molecular Sequence Data , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neuropeptides , Pheochromocytoma/analysis , RNA, Messenger/genetics , Rats , Recombinant Fusion Proteins , Tumor Cells, CulturedABSTRACT
beta-Tubulin is encoded in vertebrate genomes by a family of six to seven functional genes that produce six different polypeptide isotypes. We now document that although rat PC-12 cells express five of these isotypes, only two (classes II and III) accumulate significantly as a consequence of nerve growth factor-stimulated neurite outgrowth. In contrast to previous efforts that have failed to detect in vivo distinctions among different beta-tubulin isotypes, we demonstrate using immunoblotting with isotype-specific antibodies that three beta-tubulin polypeptides (classes I, II, and IV) are used preferentially for assembly of neurite microtubules (with approximately 70% of types I and II assembled but only approximately 50% of type III in polymer). Immunofluorescence localization shows that an additional isotype (V) is partially excluded from neurites. Distinctions in in vivo localization of the neuron-specific, class III isotype have also been directly observed using immunofluorescence and immunogold electron microscopy. The sum of these efforts documents that some in vivo functional differences between tubulin isotypes do exist.
Subject(s)
Axons/metabolism , Tubulin/metabolism , Animals , Axons/analysis , Axons/ultrastructure , Cell Line , Cell Transformation, Neoplastic/pathology , Fluorescent Antibody Technique , Immunohistochemistry , Microscopy, Electron/methods , Microtubule-Associated Proteins/analysis , Microtubules/analysis , Microtubules/metabolism , Microtubules/ultrastructure , Pheochromocytoma/analysis , Pheochromocytoma/metabolism , Pheochromocytoma/pathology , Rats , Rats, Inbred Strains , Tubulin/analysis , Tubulin/classification , Tumor Cells, Cultured/analysis , Tumor Cells, Cultured/metabolism , Tumor Cells, Cultured/pathology , tau ProteinsABSTRACT
An N-terminally directed antiserum to neurokinin B was raised in rabbits using an immunogen prepared by coupling the free-SH group of neurokinin B extended from its C-terminus by a cysteine residue (NKB-Cys) to an -NH2 group on human serum albumin using a heterobifunctional cross-linking reagent. In radioimmunoassay with 125I-Bolton-Hunter-labelled NKB-Cys as tracer, the antiserum showed no cross-reactivity with other tachykinins. An extract of a human pheochromocytoma, previously shown to contain peptides derived from preprotachykinin A, contained NKB-LI (13 pmol/g wet weight). The retention time of tumor neurokinin on reversed-phase HPLC was the same as that of synthetic neurokinin B. Peptides with the retention times of substance P, neurokinin A, neurokinin A (3-10)-peptide and neuropeptide K were also identified in the tumor extract. NKB-LI was not detected in extracts of a further nine pheochromocytomas or in five carcinoid tumors that expressed the preprotachykinin A gene.
Subject(s)
Adrenal Gland Neoplasms/analysis , Neurokinin B/analysis , Pheochromocytoma/analysis , Chromatography, High Pressure Liquid , Humans , Immune Sera , Radioimmunoassay/methodsABSTRACT
The neuronal cells of vertebrates express two beta-tubulin isotypes, called Class II and Class III, that are neuronal specific. In order to determine the distribution of the minor Class III isotype, site-directed antibodies were raised to synthetic peptides representing the carboxyl terminal, isotype-defining domains of the tubulins. These antibodies were applied to PC12 cells at various stages of differentiation. The Class III isotype was found to be expressed in undifferentiated PC12 cells as well as in cells at every stage of differentiation. The concentration of the Class III isotype, relative to the total beta-tubulin complement, did not change significantly. Indirect double immunofluorescence microscopy demonstrated that the Class III isotype was found in the soma and the neurites of differentiated PC12 cells; this spatial pattern of Class III expression paralleled the total beta-tubulin pattern. Although the anti-Class III antiserum could stain in vitro assembled neuronal microtubules in a filamentous pattern, a close examination of the Class III staining pattern in flattened PC12 cells revealed that this isotype was not incorporated into the nonaxoplasmic array of microtubules. Rather, the Class III isotype was localized in a nonfilamentous, granular pattern that was not readily extracted with nonionic detergent. Cells treated with taxol and then flattened and stained showed that the Class III isotype could be induced to assemble into microtubule bundles by taxol. Thus, the minor neuronal beta-tubulin isotype appears to be spatially specialized in its pattern of expression.
Subject(s)
Adrenal Gland Neoplasms/analysis , Immunoglobulin Isotypes/analysis , Neurons/analysis , Pheochromocytoma/analysis , Tubulin/analysis , Adrenal Gland Neoplasms/ultrastructure , Animals , Antibody Specificity , Antigens/immunology , Cell Differentiation , Fluorescent Antibody Technique , Immune Sera/immunology , Immunoglobulin Isotypes/immunology , Microtubules/analysis , Pheochromocytoma/ultrastructure , Rats , Tubulin/immunology , Tumor Cells, CulturedABSTRACT
Using sequence-specific radioimmunoassays before and after cleavage with trypsin and carboxypeptidase B, we have examined the occurrence and molecular nature of cholecystokinin (CCK) and gastrin peptides in bioactive (i.e. alpha-carboxyamidated) as well as non-amidated precursor forms in extracts from 13 human pheochromocytomas. All but one tumour contained amidated CCK, but only in moderate amounts (less than or equal to 20 pmol/g tissue). In contrast to the complete sulphation in tissues which normally produce CCK (the brain and small intestine), the amidated adrenal CCK peptides were poorly sulphated (less than or equal to 17%). Four pheochromocytomas, including the one without amidated CCK, contained between 28 and 0.2 pmol amidated gastrin/g, mainly in the form of sulphated gastrin-17. In addition, all tumours contained biosynthetic precursors of both CCK and gastrin. In most extracts there was more precursor than bioactive peptide(s), the progastrin concentration ranging up to 338 pmol/g. The results show that pheochromocytomas synthesize CCK and gastrin. The posttranslational processing differs, however, markedly from that of the principal CCK and gastrin producing tissues, with respect to both proteolytic cleavages and amino acid derivatization. This emphasizes that accurate quantitation in tumours requires assays which measure the translation products irrespective of their degree of processing.
Subject(s)
Adrenal Gland Neoplasms/analysis , Cholecystokinin/genetics , Gastrins/genetics , Pheochromocytoma/analysis , Adrenal Gland Neoplasms/genetics , Amides/metabolism , Amino Acid Sequence , Cholecystokinin/analysis , Chromatography, Gel , Gastrins/analysis , Humans , Pheochromocytoma/genetics , Radioimmunoassay , Sulfates/metabolismABSTRACT
The immunoreactive (IR) human N-terminal (hNT) of pro-opiomelanocortin (POMC) was measured by specific radioimmunoassay (RIA) and characterized by molecular sieving chromatography, concanavalin A-affinity chromatography and reversed-phase high-performance liquid chromatography (HPLC). The IR hNT levels were 380 +/- 144 ng/g wet wt (mean +/- SD) in the adrenal medulla (N:6), 21.6 +/- 6 ng/g wet wt in the adrenal cortex (N:6), and 45.6% ng/g wet wt in pheochromocytoma tissues (N:3). The IR hNT content of the adrenal medulla was found to be at least twice as high as that of the IR ACTH on a molar basis. Molecular sieving chromatography of IR hNT and IR gamma-3-melanotropin (MSH) showed two major molecular forms (apparent molecular weights of 14 and 12 kilodalton). These major forms were also separable using reversed-phase HPLC. In addition, a part of the IR ACTH material from the adrenal medulla extracts was eluted with an apparent molecular weight of 12 kilodalton. This latter form of IR ACTH was also separated from authentic human ACTH (1-39) by HPLC. Results obtained from concanavalin A-agarose chromatography suggest that one part of the IR gamma-3-MSH material from the adrenal medulla might be non-glycosylated. These results indicate the presence of IR hNT and IR gamma-3-MSH-like material in the human adrenal and also suggest a different processing pathway for POMC from that in the pituitary gland.
Subject(s)
Adrenal Gland Neoplasms/analysis , Adrenal Medulla/analysis , Adrenocorticotropic Hormone/analysis , Neurotensin/analysis , Pheochromocytoma/analysis , Pro-Opiomelanocortin/analysis , beta-Endorphin/analysis , Adrenal Cortex/analysis , Chromatography, Affinity , Chromatography, Gel , Chromatography, High Pressure Liquid , Epinephrine/analysis , Humans , Molecular Weight , RadioimmunoassayABSTRACT
PC12D cells, a new subline of conventional PC12 cells, respond not only to nerve growth factor but also to cyclic AMP by extending their neurites. These cells are flat in shape and are similar in appearance to PC12 cells that have been treated with nerve growth factor for a few days. In both cell lines, we have characterized the glycosaminoglycans, the polysaccharide moieties of proteoglycans, which are believed to play an important role in cell adhesion and in cell morphology. Under the present culture conditions, only chondroitin sulfate was detected in the media from PC12 and PC12D cells, whereas both chondroitin sulfate and heparan sulfate were found in the cell layers. The levels of cell-associated heparan sulfate and chondroitin sulfate were about twofold and fourfold higher in PC12D cells than in PC12 cells, respectively. Compared to PC12 cells, the amounts of [35S]sulfate incorporated for 48 h into chondroitin sulfate were twofold lower but those into heparan sulfate were 35% higher in PC12D cells. The amount of chondroitin sulfate released by PC12D cells into the medium was about a half of that released by PC12 cells. The ratio of [35S]sulfate-labeled heparan sulfate to chondroitin sulfate was 6.2 in PC12D cells and 2.2 in PC12 cells. These results suggest that there may be some correlation between the increase in content of glycosaminoglycans and the change in cell morphology, which is followed by neurite outgrowth.
Subject(s)
Adrenal Gland Neoplasms/analysis , Glycosaminoglycans/analysis , Pheochromocytoma/analysis , Adrenal Gland Neoplasms/metabolism , Adrenal Gland Neoplasms/pathology , Animals , Chondroitin Sulfates/analysis , Chondroitin Sulfates/metabolism , Electrophoresis, Cellulose Acetate , Glycosaminoglycans/metabolism , Heparitin Sulfate/analysis , Heparitin Sulfate/metabolism , Pheochromocytoma/metabolism , Pheochromocytoma/pathology , Rats , Sulfates/metabolism , Sulfur Radioisotopes , Tumor Cells, CulturedABSTRACT
High levels of the neuron-specific protein kinase C substrate, B-50 (= GAP43), are present in neurites and growth cones during neuronal development and regeneration. This suggests a hitherto nonelucidated role of this protein in neurite outgrowth. Comparable high levels of B-50 arise in the pheochromocytoma PC12 cell line during neurite formation. To get insight in the putative growth-associated function of B-50, we compared its ultrastructural localization in naive PC12 cells with its distribution in nerve growth factor (NGF)- or dibutyryl cyclic AMP (dbcAMP)-treated PC12 cells. B-50 immunogold labeling of cryosections of untreated PC12 cells is mainly associated with lysosomal structures, including multivesicular bodies, secondary lysosomes, and Golgi apparatus. The plasma membrane is virtually devoid of label. However, after 48-h NGF treatment of the cells, B-50 immunoreactivity is most pronounced on the plasma membrane. Highest B-50 immunoreactivity is observed on plasma membranes surrounding sprouting microvilli, lamellipodia, and filopodia. Outgrowing neurites are scattered with B-50 labeling, which is partially associated with chromaffin granules. In NGF-differentiated PC12 cells, B-50 immunoreactivity is, as in untreated cells, also associated with organelles of the lysosomal family and Golgi stacks. B-50 distribution in dbcAMP-differentiated cells closely resembles that in NGF-treated cells. The altered distribution of B-50 immunoreactivity induced by differentiating agents indicates a shift of the B-50 protein towards the plasma membrane. This translocation accompanies the acquisition of neuronal features of PC12 cells and points to a neurite growth-associated role for B-50, performed at the plasma membrane at the site of protrusion.
Subject(s)
Membrane Proteins/analysis , Nerve Growth Factors/pharmacology , Nerve Tissue Proteins/analysis , Neurons/analysis , Pheochromocytoma/analysis , Animals , Axons/analysis , Bucladesine/pharmacology , Cell Differentiation , Cell Line , Cell Membrane/analysis , Chromaffin System/analysis , Chromaffin System/cytology , Chromaffin System/ultrastructure , GAP-43 Protein , Golgi Apparatus/analysis , Immunohistochemistry , Lysosomes/analysis , Microscopy, Electron , Microvilli/analysis , Neurons/ultrastructure , Pheochromocytoma/ultrastructure , Pseudopodia/analysisABSTRACT
An autopsied case of a malignant paraganglioma of the posterior thoracic cavity is reported. A 68-year-old man had complained of chest discomfort, and serial examinations revealed a functioning paraganglioma with bone metastasis. After death a pathological examination revealed that the tumors consisted of alveolarly arranged cells and well developed capillary vessels. Numerous neurosecretory granules were observed on viewing by electron microscopy. An immunohistochemical examination showed that most of the tumor cells were positive for NSE, while only a few cells were positive for the S-100 protein. These results indicate that a paraganglioma originating from the aortic sympathetic paraganglia had similar features of a carcinoid and a neuroblastoma.
Subject(s)
Paraganglioma/pathology , Thoracic Neoplasms/pathology , Adrenal Gland Neoplasms/analysis , Aged , Carcinoid Tumor/analysis , Cytoplasmic Granules/ultrastructure , Humans , Immunohistochemistry , Male , Neuroblastoma/analysis , Paraganglioma/analysis , Paraganglioma/ultrastructure , Pheochromocytoma/analysis , Phosphopyruvate Hydratase/analysis , S100 Proteins/analysis , Thoracic Neoplasms/analysis , Thoracic Neoplasms/ultrastructureABSTRACT
We report a case of phaeochromocytoma in which the tumour was a single 10 cm adrenal cyst. The cyst fluid contained noradrenaline and adrenaline in concentrations 100 to 200 fold higher than are seen in the serum of phaeochromocytoma patients. Possibly cystic tumours containing large amounts of catecholamine may if inadvertently compressed at operation, present a greater surgical hazard than solid tumours.